Description: This panel discusses the new customers, new forms of risk-sharing and new ways of reinsuring these risks. It also looks at the future in this rapidly changing market. From Record of Society of Actuaries, Vol. 22, No. 2.

Description: The presenters describe the process payers and employers can use to evaluate emerging medical device technologies, recent or pending FDA submissions for prescription drugs and experimental treatments that impact patient care, resource utilization and health care expenditures. Learn the process of identifying and selecting impactful treatments (Horizon Scanning) and quantifying the financial cost of new technologies before they arrive in the market. These workflows can be leveraged by actuaries, healthcare economists, clinicians and pharmacists from a payer (Commercial and Medicare) and employer perspective for self-funded plans. Walk through sample models that illustrate how costs for emerging technologies and treatments can be modeled.

Description: 1993 SOA Meeting, Quebec. This session is about how reinsurers are adapting to market changes. Topics included: 1. How reinsurers are adapting to changes driving direct writers. 2. Is gIobalization of reinsurance having a major effect? 3. In what ways has the reinsurance industry changed over the years and in what ways has it not changed?

Description: This document summarizes a meeting of the Reinsurance Section that occurred at the October 1982 Society of Actuaries annual Meeting in Washington D.C. The meeting consisted of a discussion related to the role and purpose of the section, a discussion of problems and pitfalls related to reinsurance treaties, and discussions related to choosing a reinsurer.

Description: Panelists discuss Lloyd's of London, its past difficulties, and its future role in the reinsurance market. From the Record of the Society of Actuaries, Vol. 23, No. 1.

Description: In this session 116 PD of the New York Annual Meeting the panel discusses factors which led to the development of alternative risk transfer transactions in the property and casualty markets, and review techniques used to transfer and trade insurance risks within the capital markets. From the Record of the Society of Actuaries, Vol. 24, No. 3.

Description: CEOs of four of the world's leading life reinsurance companies discuss their views on the directions in which the life reinsurance industry is heading. Topics include an explanation of how changes in the world are impacting reinsurers and what actions are being taken by reinsurers to deal with these changes. From the 2002 Record of Society of Actuaries, Volume 28, No. 3. Session 107I of the Boston Annual Meeting.

Description: The session from the 2003 SOA Orlando Meeting covers workers' compensation carve-out, spiral and medical reinsurance, GMDB reinsurance and select and ultimate term. It also discusses the lessons learned from the reinsurance disasters. From the Record of the Society of Actuaries, Volume 29, No. 3.

Description: The reinsurance market is experiencing unprecedented growth in both frequency and severity of catastrophic medical claims. Most experts identify specialty drugs, new gene therapies and high-intensity hospital in-patient stays as contributing factors. With Rx claims, high-cost drug protocols are creating chronic high-cost cases over multiple years. What can actuaries do to rapidly identify these cases? If identified, what techniques can be used to reduce or manage cost? Panel will include a nationally recognized consulting actuary, health plan executive and reinsurance executive.

Description: State insurance regulators discuss transfer of risk, letters of credit, surplus relief, mirror reserving, offshore reinsurance, and accounting credit for reinsurance. From the 1987 Record of Society of Actuaries, Vol. 13, No. 4B.